- Fund Type: Open-End Fund
- Objective: Sector Fund-Health & Biotech
- Asset Class: Equity
- Geographic Focus: Global
Adamant Global Biotech
+ Add to WatchlistADGLBII:SW
1,914.80 CHF 60.87 3.08%As of 11:24:00 ET on 05/16/2013.
Snapshot for Adamant Global Biotech (ADGLBII)
| Year To Date: | +44.16% | 3-Month: | +32.37% | 3-Year: | - | 52-Week Range: | 1,248.19 - 1,981.50 |
|---|---|---|---|---|---|---|---|
| 1-Month: | +14.82% | 1-Year: | +46.35% | 5-Year: | - | Beta vs SMI: | 0.93 |
Fund Profile & Information for ADGLBII
Adamant Global Biotech is an open-end fund incorporated in Switzerland. The objective of the Fund is to obtain long-term capital growth with active management. The Fund invests on a global basis in the shares of companies in the biotech sector.
| Inception Date: | 10-15-2010 | Telephone: | +41 800 850 050 |
|---|---|---|---|
| Managers: | - | ||
| Web Site: | www.zkb.ch/fonds | ||
Fundamentals for ADGLBII
| NAV | (on 2013-05-16) 1,914.80 |
|---|---|
| Assets (M) | (on 2013-05-16) 123.77 |
| Fund Leveraged | N |
| Minimum Investment | 100,000.00 |
| Minimum Subsequent Investment | - |
Dividends for ADGLBII
| Dividend Type | Omitted |
|---|---|
| Dividend Frequency | Irreg |
| Last Dividend Net | - |
| Dividend Yield (ttm) | - |
Fees & Expenses for ADGLBII
| Front Load | 1.20 |
|---|---|
| Back Load | 1.00 |
| Current Mgmt Fee | 1.20 |
| Redemption Fee | 1.00 |
| 12b1 Fee | - |
| Expense Ratio | 1.23 |
Top Fund Holdings for ADGLBII
Filing Date: 01/31/2013| Name | Position | Value | % of Total |
|---|---|---|---|
| Regeneron Pharmaceuticals Inc | 49,500 | 7,839,432 | 8.777% |
| Amgen Inc | 90,000 | 7,003,020 | 7.840% |
| Celgene Corp | 75,000 | 6,757,731 | 7.566% |
| Gilead Sciences Inc | 186,000 | 6,680,976 | 7.480% |
| Biogen Idec Inc | 43,000 | 6,110,766 | 6.841% |
| Perrigo Co | 57,000 | 5,216,318 | 5.840% |
| Alexion Pharmaceuticals Inc | 59,954 | 5,130,737 | 5.744% |
| Vertex Pharmaceuticals Inc | 76,500 | 3,119,073 | 3.492% |
| Salix Pharmaceuticals Ltd | 70,000 | 3,052,907 | 3.418% |
| BioMarin Pharmaceutical Inc | 53,000 | 2,648,799 | 2.966% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page